PDF《2018 第一季度报告》

31 March

2018 (the Quarter ), together with the unaudited comparative figures for the corresponding period of 2017. CONDENSED CONSOLIDATED STATEMENT OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME (UNAUDITED) 简明综合损益及其他全面收益表 (未经审核) For the three months ended

31 March

2018 截至二零一八年三月三十一日止三个月 For the three months ended

31 March 截至三月三十一日止三个月

2018 2017 二零一八年 二零一七年 (Unaudited) (Unaudited) (未经审核) (未经审核) Note RMB'

000 RMB'

000 附注 人民币千元 人民币千元 Revenue 收入

3 204,674 159,755 Cost of Sales 销售成本 (90,408) (81,944) Gross profit 毛利 114,266 77,811 Other revenue 其他收入

3 1,864

745 Other net income 其他收入净额

3 2,223

284 Selling and distribution expenses 销售及分销开支 (78,001) (41,642) Administrative expenses 行政开支 (13,672) (12,784) Other operating expenses 其他经营开支 (7,727) (5,759) Profit from operations 经营溢利 18,953 18,655 季度业绩 (未经审核) 本公司董事会 ( 「董事会」 ) 欣然呈列本公司及其 附属公司 (统称 「本集团」 ) 截至二零一八年三月 三十一日止三个月 ( 「本季度」 ) 之未经审核综合业 绩连同二零一七年同期之未经审核比较数字.

3 深圳市海王英特龙生物技术股份有限公司 2018年第一季度报告 CONDENSED CONSOLIDATED STATEMENT OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME (UNAUDITED) 简明综合损益及其他全面收益表 (未经审核) For the three months ended

31 March

2018 截至二零一八年三月三十一日止三个月 For the three months ended

31 March 截至三月三十一日止三个月

2018 2017 二零一八年 二零一七年 (Unaudited) (Unaudited) (未经审核) (未经审核) Note RMB'

000 RMB'

000 附注 人民币千元 人民币千元 Finance costs 财务成本

4 (379) (737) Profit before taxation 除税前溢利

4 18,574 17,918 Income tax expense 所得税开支

5 (3,952) (3,703) Profit and total comprehensive 期内溢利及全面 income for the period 收益总额 14,622 14,215 Profit and total comprehensive income 以下各项应占期内溢利及 for the period attributable to: 全面收益总额: Owners of the Company 本公司拥有人 12,727 11,951 Non-controlling interests 非控股权益 1,895 2,264 Earnings per share for profit attributable 期内本公司拥有人应占 to the owners........